AMIKACIN THERAPY FOR SERIOUS GRAM-NEGATIVE INFECTION

被引：19
|
作者：
POLLOCK, AA
BERGER, SA
RICHMOND, AS
SIMBERKOFF, MS
RAHAL, JJ
机构：
[1] VET ADM HOSP,DIV INFECT DIS,NEW YORK,NY 10010
[2] NYU,DEPT MED,NEW YORK,NY 10003
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1977年 / 237卷 / 06期
关键词：
D O I：
10.1001/jama.237.6.562
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：562 / 564
页数：3
相关论文
共 50 条
  • [21] CEFOTAXIME THERAPY OF SERIOUS MULTIRESISTANT GRAM-NEGATIVE BACILLARY INFECTIONS
    VANLAETHEM, Y
    CLUMECK, N
    VANHOOF, R
    GEORGE, C
    RAPIN, M
    BUTZLER, JP
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1981, 7 (04) : 405 - 406
  • [22] NEWER ANTIBIOTICS IN INITIAL THERAPY OF SERIOUS GRAM-NEGATIVE DISEASE
    CARRUTHERS, M
    CLINICAL MEDICINE/US, 1970, 77 (02): : 27 - +
  • [23] Treatments for serious Gram-negative infections
    Rello, J.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S58 - S59
  • [24] MECILLINAM IN SERIOUS GRAM-NEGATIVE INFECTIONS
    ROSENBERGER, R
    KING, JW
    CLINICAL RESEARCH, 1981, 29 (02): : A395 - A395
  • [25] AMIKACIN THERAPY OF SEVERE INFECTIONS PRODUCED BY GRAM-NEGATIVE BACILLI RESISTANT TO GENTAMICIN
    VALDIVIESO, M
    BODEY, GP
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1977, 273 (02): : 177 - 184
  • [26] SERUM CONCENTRATIONS AND INHIBITORY RATIOS DURING AMIKACIN THERAPY OF GRAM-NEGATIVE INFECTIONS
    FARCHIONE, LA
    CHUDZIK, GM
    JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 18 (8-9): : 432 - 438
  • [27] AMIKACIN IN THE TREATMENT OF INFECTIONS DUE TO GRAM-NEGATIVE MICROORGANISMS
    AGUIRRE, CS
    INVESTIGACION MEDICA INTERNACIONAL, 1982, 9 (03): : 207 - 210
  • [28] TRANSFERABLE AMIKACIN RESISTANCE IN GRAM-NEGATIVE BACTERIAL ISOLATES
    KALLOVA, J
    MACICKOVA, T
    MAJTANOVA, A
    AGHOVA, A
    ADAM, D
    KETTNER, M
    CHEMOTHERAPY, 1995, 41 (03) : 187 - 192
  • [29] RESISTANCE TO AMIKACIN AND SISOMICIN IN GRAM-NEGATIVE BACILLI AND STAPHYLOCOCCI
    SOARES, LA
    REVISTA DE MICROBIOLOGIA, 1988, 19 (02): : 141 - 145
  • [30] The role of carbapenems in initial empiric therapy of serious gram-negative infections
    Nicolau, David P.
    Ramphal, Reuben
    Ambrose, Paul G.
    Rahal, James J.
    Owens, Robert C., Jr.
    FORMULARY, 2007, : 8 - 10
12345